Avalo Therapeutics

AVTX · NASDAQ

$12.36+$0.77 (+6.64%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $11.59

Latest news

Press releaseSep 29, 4:01 PM ETGlobe Newswire
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Press releaseSep 23, 7:00 AM ETGlobe Newswire
Avalo Therapeutics to Present at the European Academy of Dermatology and Venereology (EADV) 2026 Congress
Press releaseSep 4, 4:05 PM ETGlobe Newswire
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Press releaseSep 3, 7:00 AM ETGlobe Newswire
Avalo Therapeutics to Participate in Upcoming Investor Conferences
Press releaseAug 6, 7:00 AM ETGlobe Newswire
Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates
Press releaseJul 22, 7:00 AM ETGlobe Newswire
Avalo Therapeutics to Participate in the BTIG Biotechnology Conference
Press releaseJun 26, 7:00 AM ETGlobe Newswire
Avalo Therapeutics to Join the Russell 2000® and Russell 3000® Indexes
Press releaseJun 23, 7:00 AM ETGlobe Newswire
Avalo Therapeutics Appoints Ron Philip to Board of Directors
Press releaseJun 16, 7:00 AM ETGlobe Newswire
Avalo Therapeutics Expands Pipeline with AVTX-010, a Long-Acting Next-Generation Anti-IL-1β Antibody
Press releaseMay 22, 4:01 PM ETGlobe Newswire
Avalo Therapeutics Announces Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
Press releaseMay 13, 7:00 AM ETGlobe Newswire
Avalo Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates
NewsMay 6, 2:09 PM ETEvette Mitkov
Avalo Therapeutics Stock Soars After Positive LOTUS Trial Results
NewsMay 6, 1:05 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
NewsMay 6, 8:06 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
NewsMay 6, 7:15 AM ET
Market-Moving News for May 6th
NewsMay 6, 4:44 AM ETMohd Haider
Avalo Therapeutics Stock Jumps 33% In Pre-Market Session: Here's Why
Press releaseMay 5, 4:01 PM ETGlobe Newswire
Avalo Therapeutics Achieves Positive Topline Results in Phase 2 LOTUS Trial of Abdakibart (AVTX-009) in Moderate to Severe Hidradenitis Suppurativa
NewsMar 23, 7:11 AM ET
Earnings Scheduled For March 23, 2026
NewsMar 23, 7:10 AM ET
Avalo Therapeutics Q4 EPS $(0.48) Beats $(1.47) Estimate, Sales $59.000K Down From $192.000K YoY
NewsMar 19, 5:05 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
Press releaseFeb 24, 7:00 AM ETGlobe Newswire
Avalo Therapeutics to Participate in Upcoming Investor Conferences
Press releaseFeb 4, 7:00 AM ETGlobe Newswire
Avalo Therapeutics to Participate in Upcoming Investor Conferences
NewsFeb 2, 2:25 PM ETVandana Singh
Avalo Therapeutics Stock Has More Than 200% Upside? Analyst Breaks Down Bull And Bear Case
Press releaseNov 3, 7:00 AM ETGlobe Newswire
Avalo Therapeutics to Participate in Upcoming Investor Conferences
NewsSep 29, 5:07 AM ETAvi Kapoor
Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
Press releaseAug 27, 7:00 AM ETGlobe Newswire
Avalo Therapeutics to Participate in Upcoming Investor Conferences
NewsAug 1, 8:07 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
Press releaseJun 23, 7:00 AM ETGlobe Newswire
Avalo Therapeutics to Participate in Upcoming Investor Conferences
Press releaseMay 27, 10:05 AM ETGlobe Newswire
Avalo Therapeutics to Participate in Upcoming Investor Conferences
NewsMay 14, 5:05 PM ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
NewsMay 12, 8:08 AM ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
Press releaseApr 30, 7:00 AM ETGlobe Newswire
Avalo Therapeutics to Participate in The Citizens Life Sciences Conference
NewsMar 25, 3:20 PM ETVandana Singh
Avalo Therapeutics 'Represents An Attractive Pure-Play,' Analyst Initiates Coverage With Over 300% Stock Upside
Press releaseFeb 24, 7:00 AM ETGlobe Newswire
Avalo Therapeutics to Participate in Upcoming Investor Conferences
Press releaseFeb 4, 8:00 AM ETGlobe Newswire
Avalo Therapeutics to Present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference
Press releaseNov 11, 7:00 AM ETGlobe Newswire
Avalo Therapeutics to Present at Upcoming Investor Conferences
Press releaseNov 4, 7:30 AM ETPRNewswire
Actinium Pharmaceuticals Appoints Accomplished Biopharma Industry Executive June Almenoff, M.D., Ph.D. to its Board of Directors
Press releaseSep 4, 8:00 AM ETBusiness Wire
KaliVir Immunotherapeutics Appoints Schond Greenway as Chief Financial Officer
Press releaseSep 4, 7:00 AM ETGlobe Newswire
Avalo Announces Participation in September Investor Conferences

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Avalo Therapeutics to Present at the European Academy of Dermatology and Venereology (EADV) 2026 Congress

Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Avalo Therapeutics to Participate in Upcoming Investor Conferences

Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates

Avalo Therapeutics to Participate in the BTIG Biotechnology Conference

Avalo Therapeutics to Join the Russell 2000® and Russell 3000® Indexes

Avalo Therapeutics Appoints Ron Philip to Board of Directors

Avalo Therapeutics Expands Pipeline with AVTX-010, a Long-Acting Next-Generation Anti-IL-1β Antibody

Avalo Therapeutics Announces Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

Avalo Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates

Avalo Therapeutics Stock Soars After Positive LOTUS Trial Results

12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Market-Moving News for May 6th

Avalo Therapeutics Stock Jumps 33% In Pre-Market Session: Here's Why

Avalo Therapeutics Achieves Positive Topline Results in Phase 2 LOTUS Trial of Abdakibart (AVTX-009) in Moderate to Severe Hidradenitis Suppurativa

Earnings Scheduled For March 23, 2026

Avalo Therapeutics Q4 EPS $(0.48) Beats $(1.47) Estimate, Sales $59.000K Down From $192.000K YoY

12 Health Care Stocks Moving In Thursday's After-Market Session

Avalo Therapeutics to Participate in Upcoming Investor Conferences

Avalo Therapeutics to Participate in Upcoming Investor Conferences

Avalo Therapeutics Stock Has More Than 200% Upside? Analyst Breaks Down Bull And Bear Case

Avalo Therapeutics to Participate in Upcoming Investor Conferences

Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket

Avalo Therapeutics to Participate in Upcoming Investor Conferences

12 Health Care Stocks Moving In Friday's Pre-Market Session

Avalo Therapeutics to Participate in Upcoming Investor Conferences

Avalo Therapeutics to Participate in Upcoming Investor Conferences

12 Health Care Stocks Moving In Wednesday's After-Market Session

12 Health Care Stocks Moving In Monday's Pre-Market Session

Avalo Therapeutics to Participate in The Citizens Life Sciences Conference

Avalo Therapeutics 'Represents An Attractive Pure-Play,' Analyst Initiates Coverage With Over 300% Stock Upside

Avalo Therapeutics to Participate in Upcoming Investor Conferences

Avalo Therapeutics to Present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference

Avalo Therapeutics to Present at Upcoming Investor Conferences

Actinium Pharmaceuticals Appoints Accomplished Biopharma Industry Executive June Almenoff, M.D., Ph.D. to its Board of Directors

KaliVir Immunotherapeutics Appoints Schond Greenway as Chief Financial Officer

Avalo Announces Participation in September Investor Conferences